Table 1.
Characteristic | All (n = 577) | Women (n = 364) | Men (n = 213) | p-Value |
---|---|---|---|---|
Male gender, n (%) | 213 (36.9) | |||
Age (years), mean (SD) | 65 (19) | 67 (18) | 62 (19) | 0.003 |
Diabetes mellitus, n (%) | 114 (19.8) | 71 (19.5) | 43 (20.2) | 0.84 |
Arterial Hypertension, n (%) | 318 (55.1) | 221 (60.7) | 97 (45.5) | <0.001 |
Haemoglobin (g/dL), mean (SD) | 12.5 (2.3) | 12.1 (2.0) | 13.1 (2.2) | <0.001 |
Creatinine (mg/dL), median (IQR) | 0.93 (0.72–1.30) | 0.90 (0.70–1.30) | 1.00 (0.80–1.30) | 0.003 |
Lymphocytes (cells/µL), median (IQR) | 1600 (1015–2270) | 1740 (1110–2340) | 1410 (950–2030) | 0.001 |
Platelets | 205 (159–267) | 220 (167–287) | 187 (146–239) | <0.001 |
C–Reactive Protein (mg/L), median (IQR) | 39.8 (15.7–93.7) | 34.8 (14.2–79.6) | 51.9 (17.7–115.4) | 0.005 |
BNP (pg/mL), median (IQR) | 283.0 (85.9–744.6) | 284.8 (88.9–759.1) | 278.8 (80.8–679.5) | 0.87 |
Central/bilateral PE, n (%) | 175 (30.4) | 115 (31.8) | 60 (28.2) | 0.36 |
idiopathic PE, n (%) | 376 (65.2) | 237 (65.1) | 139 (65.3) | 0.97 |
Thrombolytic therapy, n (%) | 67 (11.6) | 45 (12.4) | 22 (10.3) | 0.46 |
All–cause death, n (%) | 240 (41.6) | 140 (38.5) | 100 (46.9) | 0.05 |
BNP: B type natriuretic peptide; IQR: interquartile range; PE: pulmonary embolism; SD: standard deviation.